MediciNova, Inc.
Overview
MediciNova, Inc. is a publicly-traded biopharmaceutical company focused on acquiring and developing small molecule therapeutics for the treatment of serious diseases with unmet medical needs. The company’s development pipeline targets areas such as neurology, respiratory, and liver diseases, with a commitment to advancing its clinical programs.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to MediciNova, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this MediciNova, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.